• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by Hinge Health Inc.

    4/27/26 7:26:02 AM ET
    $HNGE
    EDP Services
    Technology
    Get the next $HNGE alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    Hinge Health, Inc.

    (Name of Issuer)


    Ordinary Shares

    (Title of Class of Securities)




    433313103

    (CUSIP Number)
    03/31/2026

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)




    schemaVersion:


    SCHEDULE 13G

    CUSIP Number(s):
    433313103


    1Names of Reporting Persons

    HANSAINVEST Hanseatische Investment-Limited Co
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    GERMANY
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    1,476,600.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    1,476,600.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,476,600.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    2.7 %
    12Type of Reporting Person (See Instructions)

    OO, FI

    Comment for Type of Reporting Person:  The shares are held for the account of investment funds managed by HANSAINVEST. Under German law HANSAINVEST is not the legal owner of these shares which are co-owned by the investors. However by operation of German law (Sec. 93 (1) KAGB) HANSAINVEST is authorized to exercise the ownership rights to vote the shares and has full dipositive power over the shares. The ownership information above is as of 31th of December 2025.


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Hinge Health, Inc.
    (b)Address of issuer's principal executive offices:

    455 MARKET STREET, 7TH FLOOR, SAN FRANCISCO, CALIFORNIA, 94105.
    Item 2. 
    (a)Name of person filing:

    Pascal Reyer
    (b)Address or principal business office or, if none, residence:

    Kapstadtring 8 22297 Hamburg Germany
    (c)Citizenship:

    German
    (d)Title of class of securities:

    Ordinary Shares
    (e)CUSIP Number(s):

    433313103
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    German KVG (Investment Management Company)
    Item 4.Ownership
    (a)Amount beneficially owned:

    1,476,600.00
    (b)Percent of class:

    2.65  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    1,476,600.00

     (ii) Shared power to vote or to direct the vote:

    0

     (iii) Sole power to dispose or to direct the disposition of:

    1,476,600.00

     (iv) Shared power to dispose or to direct the disposition of:

    0

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Not Applicable
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ? 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to Investment Management Company (KVG) is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    HANSAINVEST Hanseatische Investment-Limited Co
     
    Signature:Pascal Reyer
    Name/Title:Director of Reporting
    Date:04/27/2026
    Get the next $HNGE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HNGE

    DatePrice TargetRatingAnalyst
    1/9/2026$68.00Overweight
    Wells Fargo
    9/5/2025$56.00Neutral
    Robert W. Baird
    7/14/2025$58.00Mkt Outperform
    Citizens JMP
    6/16/2025Outperform
    William Blair
    6/16/2025$48.00Buy
    Truist
    6/16/2025$48.00Buy
    Stifel
    6/16/2025$45.00Outperform
    Raymond James
    6/16/2025$41.00Overweight
    Piper Sandler
    More analyst ratings

    $HNGE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wells Fargo initiated coverage on Hinge Health with a new price target

    Wells Fargo initiated coverage of Hinge Health with a rating of Overweight and set a new price target of $68.00

    1/9/26 9:05:22 AM ET
    $HNGE
    EDP Services
    Technology

    Robert W. Baird initiated coverage on Hinge Health with a new price target

    Robert W. Baird initiated coverage of Hinge Health with a rating of Neutral and set a new price target of $56.00

    9/5/25 7:59:54 AM ET
    $HNGE
    EDP Services
    Technology

    Citizens JMP initiated coverage on Hinge Health with a new price target

    Citizens JMP initiated coverage of Hinge Health with a rating of Mkt Outperform and set a new price target of $58.00

    7/14/25 8:51:47 AM ET
    $HNGE
    EDP Services
    Technology

    $HNGE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Insight Holdings Group, Llc converted options into 426,171 shares and sold $38,446,957 worth of shares (426,171 units at $90.21) (SEC Form 4)

    4 - Hinge Health, Inc. (0001673743) (Issuer)

    7/9/26 9:17:10 PM ET
    $HNGE
    EDP Services
    Technology

    Director Sloat Tyler was granted 246 shares, increasing direct ownership by 2% to 10,210 units (SEC Form 4)

    4 - Hinge Health, Inc. (0001673743) (Issuer)

    7/7/26 7:46:39 PM ET
    $HNGE
    EDP Services
    Technology

    Chief Financial Officer Budge James covered exercise/tax liability with 4,614 shares, decreasing direct ownership by 1% to 430,786 units (SEC Form 4) to satisfy tax liability

    4 - Hinge Health, Inc. (0001673743) (Issuer)

    7/2/26 4:41:59 PM ET
    $HNGE
    EDP Services
    Technology

    $HNGE
    SEC Filings

    View All

    SEC Form 144 filed by Hinge Health Inc.

    144 - Hinge Health, Inc. (0001673743) (Subject)

    6/29/26 5:20:44 PM ET
    $HNGE
    EDP Services
    Technology

    Hinge Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Hinge Health, Inc. (0001673743) (Filer)

    6/9/26 4:06:49 PM ET
    $HNGE
    EDP Services
    Technology

    Hinge Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Hinge Health, Inc. (0001673743) (Filer)

    6/4/26 4:19:58 PM ET
    $HNGE
    EDP Services
    Technology

    $HNGE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hinge Health to announce second quarter 2026 financial results on August 4, 2026

    Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the quarter ended June 30, 2026, after the U.S. financial markets close on Tuesday, August 4, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health’s vision is to scale and automate the delivery of health care. Leveraging an

    7/6/26 4:05:00 PM ET
    $HNGE
    EDP Services
    Technology

    Hinge Health adds surgery to HingeSelect, delivering a fully integrated musculoskeletal care platform

    HingeSelect now offers coordinated care covering physical therapy, specialist evaluations, imaging, non-surgical procedures, prehabilitation, surgery and post-operative recovery.Hinge Health, Inc. (NYSE:HNGE) today announced the expansion of HingeSelect to include orthopedic surgery, now delivering care across the entire musculoskeletal (MSK) journey. Members begin with first-line treatment and orthopedic evaluation to determine whether surgery is appropriate. When surgery is needed, Hinge Health supports the journey from pre-op through recovery, connecting members to high-quality surgeons through the HingeSelect network.Surgery accounts for about half of MSK costs1 with an orthopedic surger

    6/10/26 9:20:00 AM ET
    $HNGE
    EDP Services
    Technology

    Hinge Health hosts its first Investor Day and raises guidance

    Full year 2026 revenue guidance raised to a range of $818 million to $824 million, up $20 million at the midpoint from its prior range and marking 40% year-over-year growth Full year 2026 non-GAAP operating margin of 27% now expected at the midpoint Tomorrow, June 10, Hinge Health, Inc. (NYSE:HNGE) will host its inaugural Investor Day at Movement - the company's annual conference that brings employers, health plans, consultants, providers and clinical experts together to discuss the evolution of healthcare. The Investor Day presentations will begin at 1:00 pm CT and the session will be available via webcast on Hinge Health's investor relations website. During the session, investors w

    6/9/26 4:05:00 PM ET
    $HNGE
    EDP Services
    Technology

    $HNGE
    Leadership Updates

    Live Leadership Updates

    View All

    Hinge Health appoints Tyler Sloat to its board of directors

    Hinge Health, Inc. (NYSE:HNGE) today announced the addition of Tyler Sloat to its board of directors. Sloat currently serves as the Chief Financial Officer and Chief Operating Officer of Freshworks Inc., where he oversees accounting, finance, IT, security, workplace, corporate strategy and revenue enablement. "Tyler brings decades of deep operating experience," said Daniel Perez, Co-Founder and CEO, Hinge Health. "His track record of scaling public companies with operational rigor and financial discipline will be instrumental as we advance our mission to automate healthcare delivery." As a seasoned executive and board member, Sloat has nearly three decades of operational leadership guid

    3/17/26 4:05:00 PM ET
    $HNGE
    EDP Services
    Technology

    $HNGE
    Financials

    Live finance-specific insights

    View All

    Hinge Health to announce second quarter 2026 financial results on August 4, 2026

    Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the quarter ended June 30, 2026, after the U.S. financial markets close on Tuesday, August 4, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health’s vision is to scale and automate the delivery of health care. Leveraging an

    7/6/26 4:05:00 PM ET
    $HNGE
    EDP Services
    Technology

    Hinge Health reports record first quarter 2026 financial results

    Hinge Health, Inc. (NYSE:HNGE) today announced financial results for the first quarter ended March 31, 2026. "We generated $182 million in revenue this quarter with 47% year-over-year growth, well ahead of expectations, driven by the strength of a platform that automates care delivery, improves member outcomes and lowers costs," said Daniel Perez, Co-Founder and CEO, Hinge Health. "Based on this momentum, we're raising our full-year revenue outlook by approximately $64 million at the midpoint to $801 million, while expanding non-GAAP operating margin to 26%. We also recently announced our Migraine Care Program, an important step in expanding our platform. We didn't build this company to s

    5/5/26 4:05:00 PM ET
    $HNGE
    EDP Services
    Technology

    Hinge Health to announce first quarter 2026 financial results on May 5, 2026

    Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the quarter ended March 31, 2026, after the U.S. financial markets close on Tuesday, May 5, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, starting wit

    4/2/26 4:05:00 PM ET
    $HNGE
    EDP Services
    Technology